Wyoming Clinical Trials Report — July 2026

Wyoming residents considering a clinical trial should act soon if they match one of the 4 studies expected to close within the next 90 days. None of those closing studies accept healthy volunteers, and several involve advanced or metastatic small intestinal cancer. At the same time, Wyoming added 1 new recruiting trial in July, giving people with heart failure, COPD, or related pulmonary disease a new opportunity to explore.

There are currently 58 recruiting clinical trials across 11 Wyoming cities and 18 research sites. The July opening is an increase from 0 new trials in May 2026, although the state’s overall research activity remains relatively focused compared with larger states. Prospective participants should begin screening now, since eligibility reviews, medical-record checks, and appointments can take time before enrollment is complete.

A new VA-supported option for Veterans with heart or lung disease

July’s new study is a federally sponsored behavioral trial from the VA Office of Research and Development. NCT07714252, “Virtual Nurse and Social Worker Palliative Care Team to Improve Quality of Life in Veterans With Heart Failure or COPD,” plans to enroll 420 participants.

The study addresses symptoms that can substantially affect daily life for Veterans with heart failure or chronic obstructive pulmonary disease, including breathlessness, fatigue, depression, and anxiety. Its virtual care model brings together a nurse and social worker to support quality of life and symptom management. Because the intervention is behavioral rather than a new drug, it may interest eligible Veterans seeking additional care coordination and supportive services.

• NCT07714252 — Virtual nurse and social worker palliative care for Veterans with heart failure or COPD.
• Planned enrollment: 420 participants.
• Sponsor: VA Office of Research and Development.
• Study type: behavioral intervention.
• Location reported for the new-trial activity: Cheyenne.

The study is classified as federally sponsored rather than industry-sponsored. Its focus also distinguishes July from May: Wyoming recorded no new trial openings in May, while this month brought a public-sector study centered on virtual support, symptom relief, and quality of life rather than an experimental medicine.

Closing studies create a narrow window for cancer and substance-use research

The 4 trials closing within 90 days cover two broad areas: alcohol-related behavior and cancer. One study involves alcohol drinking, and another addresses craving. The remaining closing-trial listings concern malignancy and several stages or forms of small intestinal adenocarcinoma.

• Alcohol drinking — 1 closing-soon trial.
• Craving — 1.
• Malignancy and malignant solid neoplasm — 1 each.
• Metastatic small intestinal adenocarcinoma — 1.
• Stage II, IIIA, IIIB, and IV small intestinal adenocarcinoma — 1 listing each.

The condition counts overlap because a single oncology study can use several medical terms to describe its eligibility groups. People with small intestinal adenocarcinoma, advanced solid tumors, or a related diagnosis should contact the research site promptly rather than waiting until the projected closing date. The study may require pathology reports, imaging, treatment history, and confirmation of disease stage.

There are 0 healthy-volunteer opportunities among the closing trials. That does not mean healthy adults have no options statewide: 8 trials currently recruiting in Wyoming list healthy volunteers among their eligibility populations. However, none of the month’s new trials accepts healthy participants, so people without a diagnosed condition should search the existing statewide listings rather than relying on July’s new opening.

Cheyenne leads the month’s new activity, while opportunities remain statewide

Cheyenne is the only city identified with a new trial in July. The broader recruiting network reaches 11 cities and 18 research sites, indicating that Wyoming’s opportunities are distributed beyond a single location even though the month’s new activity is concentrated in the state capital.

For people outside Cheyenne, travel requirements may vary considerably by study. Some trials use virtual visits or remote assessments, while others require repeated in-person appointments, laboratory testing, imaging, or treatment at a research center. Residents should ask each site whether screening can begin remotely, how often visits are required, and whether travel assistance is available.

Wyoming’s relatively small number of sites can make geographic planning especially important. A study may be open statewide but operate at only one participating location. Searching by city as well as condition can help patients identify realistic options in Cheyenne and other communities.

Who should act now?

Patients with heart failure or COPD who are Veterans should review NCT07714252 while recruitment is active, particularly if virtual palliative-care support could fit their circumstances. People with alcohol-related concerns or eligible small intestinal cancer should prioritize the closing-soon studies because projected enrollment deadlines leave less time for referral and screening.

The July eligibility profile is limited but clear. None of the new trials includes children, and there are no female-only or male-only studies. 1 new trial includes older adults, making age-eligible Veterans with heart failure or COPD a key group to consider. Healthy adults have no newly opened opportunity this month, but 8 other recruiting trials may still provide options.

Because the new study is sponsored by the VA Office of Research and Development, Veterans may want to begin with their VA clinician or local VA research office. Patients considering the oncology or behavioral studies should bring a current medication list, relevant diagnostic records, and questions about visit schedules and participation requirements when contacting a site.

Wyoming’s research pipeline is likely to remain selective through the rest of 2026: one federally supported virtual-care study has opened, while several time-sensitive cancer and behavioral opportunities are moving toward closure. Checking listings early and confirming availability directly with research teams will give eligible residents the best chance to enter a study before recruitment changes.